Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis
Jesús Tornero-Molina; Mercedes Alperi-López; Ivan Castellví; Juan José de Agustín-de Oro; Alejandro Escudero; Rosario García-Vicuña; Miguel Ángel González-Gay; Cristina Hidalgo; Esteban Rubio; Raimon Sanmartí; Núria Casamira; Jaime Calvo-Alén;
Reumatol Clin. 2022;18:33-41
Safety and survival associated with biologic therapies: first report of the Biobadaguay on the Paraguayan-Uruguayan registry of adverse events with biologic therapies
Paloma de Abreu; Gabriela Ávila-Pedretti; Zoilo Morel; María Isabel Acosta; Sonia Cabrera-Villalba; Patricia Melgarejo; Marcos Franco; Pedro Delgadillo; Lourdes Román; Juan Gabriel Elizaur; Ernesto Paredes; Darwin Octavio Cordobilla; Daniel Palleiro; Miguel Albanese; Julio Mazzoleni;
Reumatol Clin. 2020;16P2:396-404
Biological Dose Tapering in Daily Clinical Practice: A 10 Year Follow-up Study
Mercedes Alperi-López; Sara Alonso-Castro; Isla Morante-Bolado; Rubén Queiro-Silva; José Luis Riestra-Noriega; Luis Arboleya; Francisco Javier Ballina-García;
Reumatol Clin. 2020;16P1:319-23